In this article we analyze the influence of the legal regulatory framework
in Europe, established by the two directives on medical devices and active
implantable devices, on the performance of innovation in a single European
market. First, we describe in general the possible influence of a single Eu
ropean market on innovation and the institutional features of the particula
r harmonization approach ("New Approach") we are looking at here. The empir
ical results presented derive from a survey investigation involving 150 fir
ms that we defined as best innovators in the European medical devices indus
try from a pre-survey. The results confirm that the total impact of the New
Approach regulation on firms' innovation in the long term is positive. How
ever, it also becomes clear that the impact of regulation on innovation is
limited if the factors are looked at individually and that there is a clear
difference regarding short-term effects. To improve the regulatory framewo
rk, several policy actions are recommended.